Genitourinary interventions in autosomal dominant polycystic kidney disease: Clinical recommendations for urologic and transplant surgeons

dc.contributor.authorEl-Chediak, Alissar
dc.contributor.authorDegheili, Jad A.
dc.contributor.authorKhauli, Raja Bahjat
dc.contributor.departmentSurgery
dc.contributor.departmentDivision of Urology
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T12:13:32Z
dc.date.available2025-01-24T12:13:32Z
dc.date.issued2021
dc.description.abstractAutosomal dominant polycystic kidney disease is the fourth most common single cause of end-stage renal disease worldwide with both renal and extrarenal manifestations, resulting in significant morbidity. Approaches to the management of this disease vary widely, with no broadly accepted practice guidelines. Herein, we reviewed the various surgical and interventional management options that are targeted toward treating the symptoms or addressing the resulting kidney failure. Novel treatment modalities such as celiac plexus blockade and renal denervation appear to be promising in pain relief; however, further studies are lacking. Renal cyst decortication seems to have a higher success rate in targeting cyst-related pain compared with aspiration only. In terms of requiring major surgical intervention, such as need and timing of native nephrectomy, there are several considerations when deciding on transplantation with or without a pretransplant native nephrectomy. Patients who are not candidates for native nephrectomy may consider transcatheter arterial embolization. Based on our review of the contemporary indications for genitourinary interventions in the management of autosomal dominant polycystic kidney disease, we propose an algorithm that depicts the decisionmaking process on assessing the indications and timing of native nephrectomy in patients with endstage renal disease awaiting transplant. © Başkent University 2021 Printed in Turkey. All Rights Reserved.
dc.identifier.doihttps://doi.org/10.6002/ect.2020.0292
dc.identifier.eid2-s2.0-85101478074
dc.identifier.pmid33494664
dc.identifier.urihttp://hdl.handle.net/10938/33055
dc.language.isoen
dc.publisherBaskent University
dc.relation.ispartofExperimental and Clinical Transplantation
dc.sourceScopus
dc.subjectEnd-stage renal disease
dc.subjectNative nephrectomy
dc.subjectRenal transplant complications
dc.subjectRenal transplantation
dc.subjectAlgorithms
dc.subjectClinical decision-making
dc.subjectHumans
dc.subjectKidney failure, chronic
dc.subjectPolycystic kidney, autosomal dominant
dc.subjectSurgeons
dc.subjectAlgorithm
dc.subjectAnalgesia
dc.subjectArterial embolization
dc.subjectArticle
dc.subjectDecision making
dc.subjectDecortication
dc.subjectEnd stage renal disease
dc.subjectFenestration
dc.subjectHuman
dc.subjectIntractable pain
dc.subjectKidney denervation
dc.subjectKidney failure
dc.subjectKidney function
dc.subjectKidney graft
dc.subjectKidney polycystic disease
dc.subjectKidney transplantation
dc.subjectNephrectomy
dc.subjectNerve block
dc.subjectSclerotherapy
dc.subjectTransplant surgeon
dc.subjectTreatment indication
dc.subjectChronic kidney failure
dc.subjectClinical decision making
dc.subjectSurgeon
dc.titleGenitourinary interventions in autosomal dominant polycystic kidney disease: Clinical recommendations for urologic and transplant surgeons
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2021-2764.pdf
Size:
252.66 KB
Format:
Adobe Portable Document Format

Collections